key: cord-0963016-2glq0wgg
authors: Mus, Ahmad Asnawi; Goh, Lucky Poh Wah; Marbawi, Hartinie; Gansau, Jualang Azlan
title: The Biosynthesis and Medicinal Properties of Taraxerol
date: 2022-03-30
journal: Biomedicines
DOI: 10.3390/biomedicines10040807
sha: 4234ee3f882375b679126e19e1c767a0b6dc966a
doc_id: 963016
cord_uid: 2glq0wgg

Taraxerol is a pentacyclic triterpenoid that is actively produced by some higher plants as part of a defense mechanism. The biosynthesis of taraxerol in plants occurs through the mevalonate pathway in the cytosol, in which dimethylallyl diphosphate (DMAPP) and isopentyl pyrophosphate (IPP) are first produced, followed by squalene. Squalene is the primary precursor for the synthesis of triterpenoids, including taraxerol, β-amyrin, and lupeol, which are catalyzed by taraxerol synthase. Taraxerol has been extensively investigated for its medicinal and pharmacological properties, and various biotechnological approaches have been established to produce this compound using in vitro techniques. This review provides an in-depth summary of the hypothesized taraxerol biosynthetic pathway, the medicinal properties of taraxerol, and recent developments on tissue culture for the in vitro production of taraxerol.

Despite recent advances in combinatorial chemistry, and other means of synthesis methods towards the production of essential drugs in healthcare, naturally derived compounds are still an invaluable source of medicine [1] . This is due to the minimal side effects and relatively higher biological activity of natural drugs compared to synthetic drugs [2] . Although the process of discovering effective drugs from natural raw materials is time consuming, costly, and less sustainable, advances in biotechnology could be helpful for such efforts [3] . In fact, natural products have played an important role in drug development whereby a considerable number of drugs are derived from naturally occurring compounds [4] . Today, there are more than 250 naturally derived drugs that are manufactured at large scales in the healthcare industries such as morphine, cephalosporin, and paclitaxel [5] .

Taraxerol, an oleanane-type pentacyclic triterpene, is one of the natural compounds that have been investigated extensively for its potential utilization in drug development [6] . It has received major attention for its potential use as a therapeutic agent for the treatment of various diseases [7] . Plants containing taraxerol are Hypericum perforatum [8] , Clitoria ternatea [9] , Mangifera indica [10] , and Strobilanthes crispus [11] . Taraxerol attracted wide interest among researchers due to its significant capabilities in modern pharmacology, such as its ability to act as an anti-tumor [12] , anti-microbial [13] , and anti-inflammatory agent [14] , and in the treatment of Alzheimer's disease [15] .

Thus, this review aims to further explore the distribution of taraxerol in plants, their valuable properties and activities, as well as sustainable approaches in further producing this compound.

Taraxerol, (3β)-D-Friedoolean-14-en-3-ol, is a pentacylic triterpenoid [6, 16] . Its chemical structure was first elucidated by Beaton et al. (1955) who identified that the oleanane-3-ol lacks the methyl group at position 14, with an α-methyl substituent at position 13 and a double bond between positions 14 and 15 [17] (Figure 1 ). This compound is also known by a few other synonymous names, which are isoolean-14-en-3b-ol, skimmiol, alnulin, and tiliadin. Taraxerol can be extracted from various plant families and species found in nature. However, the synthesis of taraxerol is challenging and depends on natural resources that have a negative impact on biological conservation. Hence, the ongoing research on taraxerol production and its distribution provides vital information for future investigations.

3-ol lacks the methyl group at position 14, with an α-methyl substituent at position 13 and a double bond between positions 14 and 15 [17] (Figure 1 ). This compound is also known by a few other synonymous names, which are isoolean-14-en-3b-ol, skimmiol, alnulin, and tiliadin. Taraxerol can be extracted from various plant families and species found in nature. However, the synthesis of taraxerol is challenging and depends on natural resources that have a negative impact on biological conservation. Hence, the ongoing research on taraxerol production and its distribution provides vital information for future investigations. 

Members of the Asteraceae family comprise the greatest number of taraxerol-containing taxa, followed by the Euphorbiaceae and Malvaceae families (Table 1) . It should be noted that within the Euphorbiaceae family, species in the Euphorbia genus have shown considerable accumulation of taraxerol. The most prominent source of taraxerol was found to be chiefly concentrated in the leaves for most taxa [11, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] , followed by the roots [9, 12, [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] and finally the stems [36, 38, [53] [54] [55] [56] [57] [58] [59] . Some literature has also managed to isolate taraxerol from flowers (Table 1) . However, the distribution of taraxerol is highly diverse in plants, and taraxerol content differ in different parts of plants and across different plant species. 

Members of the Asteraceae family comprise the greatest number of taraxerol-containing taxa, followed by the Euphorbiaceae and Malvaceae families (Table 1) . It should be noted that within the Euphorbiaceae family, species in the Euphorbia genus have shown considerable accumulation of taraxerol. The most prominent source of taraxerol was found to be chiefly concentrated in the leaves for most taxa [11, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] , followed by the roots [9, 12, [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] and finally the stems [36, 38, [53] [54] [55] [56] [57] [58] [59] . Some literature has also managed to isolate taraxerol from flowers (Table 1) . However, the distribution of taraxerol is highly diverse in plants, and taraxerol content differ in different parts of plants and across different plant species. 

The biosynthesis pathways of taraxerol in plants have yet to be definitively elucidated. Swain et al. (2012) hypothesized that the biosynthesis of taraxerol in plants begins from the mevalonic acid pathway in the plant's cell cytoplasm [94] . The mevalonate pathway begins with acetyl-CoA and ends with the production of IPP and DMAPP, which are the basic building blocks of various terpenoid compounds including taraxerol [95, 96] . The DMAPP produced will then undergo condensation with IPP which is catalyzed by geranyl pyrophosphate synthase, producing geranyl pyrophosphate (GPP) that will be further subjected to condensation with IPP to produce farnesyl pyrophosphate (FPP) catalyzed by farnesyl diphosphate synthase (FPS) [29, 97] . Squalene synthase catalyzes the condensation of the FPP molecules through reduction by NADPH to produce one molecule of squalene [98, 99] . Squalene is then oxidised by NADPH and O 2 to produce 2,3-oxidosqualene, which results in the reduction of NADPH into NADP + and O 2 to H 2 O [100]. 2,3-oxidosqualene is then utilised as a precursor for the biosynthesis of various triterpenoids, starting with a proton-initiated cyclization to produce dammarenyl cation, following which subsequent rearrangement leads to the pentacylic oleanyl cation via baccharenyl and lupenyl cation intermediates [101] . A series of 1,2-hyride shifts and/or methyl groups leads to compound rearrangements. Finally, the rearrangements of compounds via taraxerol synthase eventually lead to the formation of taraxerol in plants, more specifically in the cuticular waxes [72, 100, 102] . A summary of the biosynthesis pathway is illustrated in Figure 2 . 

'Reactive oxygen species' (ROS) is a term that encompasses various oxygen free radicals produced during cellular oxidative process. These compounds pose a significant risk 

'Reactive oxygen species' (ROS) is a term that encompasses various oxygen free radicals produced during cellular oxidative process. These compounds pose a significant risk factor for various diseases. Hence, antioxidants play an important role as a phytochemical that could inhibit the oxidative process. A study reported that taraxerol isolated from the bark of Styrax japonica exhibited weak radical-scavenging activity in the DPPH assay [103] . Increasing the concentration of taraxerol from 0.05-0.5 mg/mL yielded moderate radical scavenging activity in DPPH assay [85] . Jamila et al. (2015) supported the findings from Min et al. (2004) , where taraxerol isolated from Garcinia hombroniana was found to be more potent than trolox and equipotent to gallic acid in DPPH radical scavenging activity, while in ABTS the scavenging activity of taraxerol was higher than trolox but less than gallic acid [71] . The reducing capacity of the extracts is related to the presence of biologically active compounds, particularly the hydrogendonating ability [17] . Owing to the potential chemical structure of taraxerol itself, this might explain the potent antioxidative capabilities of taraxerol. The current body of literature on taraxerol as an antioxidant provides valuable insight on this compound, but the work is not yet completed, and there are aspects that are under-explored.

Singh et al. (2002) observed that 1 mg of taraxerol compound exhibited moderate antimicrobial activity against two Gram-positive (Staphylococcus aureus and Bacillus thuringiensis) and three Gram-negative bacteria (Escherichia coli, Enterobacter cloacae, and Klebsiella pneumonia) [13] . Koay et al. (2013) investigated the minimum inhibitory concentrations (MICs) of taraxerol on several bacteria and found that the compound is active against Gram-positive Bacillus subtilis and Staphylococcus aureus at a concentration of 15.6 µg/mL but is only moderately inhibitive to the Gram-negative Escherichia coli, Klebseilla pneumonia, and Salmonella typhimurium at a concentration of 62.5 µg/mL The taraxerol antimicrobial activity is comparable to that of positive control gentamicin [11] . Meanwhile, Hernandez-Chavez et al. (2012) reported on the anti-gardial activities of taraxerol towards Giardia lambia, a parasitic protozoan [104] . It was found that taraxerol possessed strong anti-gardial activity exhibiting a growth inhibition (IC 50 ) of 50% at a concentration of 16.11 µg/mL and a growth inhibition of 90% at a concentration of 102.4 µg/mL, although the activity is lower compared to the positive control metronidazole. Another study on the cytotoxic activity of taraxerol against parasitic protozoans was conducted by Simelane et al. (2013) , targeting malaria-causing Plasmodium falcifarum and Plasmodium berghei [105] . Anti-plasmodial activities were reported for taraxerol at a concentration of more than 100 µg/mL [105] , but it was found to have no effect on mycobacteria (Mycobacterium Madagascar and M. indicuspranii), exhibiting a lower activity than the positive control chloroquine (IC 50 = 14.1 ng/mL) [85] . Thus, future studies should focus mainly on the potential of taraxerol as an anti-protozoan drug. Warfield et al. (2014) conducted studies on the efficacy of taraxerol in combating the parasitic Trypanosoma cruzi [106] . The authors characterized the affinity of taraxerol with the sterol 14α-demethylase enzyme from Trypanosoma cruzi and found that the skeletal structure of taraxerol has higa affinity towards the enzyme, therefore providing potent inhibitory activity.

In an earlier study, taraxerol at a concentration of 1 mg/disc exhibited weak antifungal activities against four types of fungi namely Aspergillus niger, Aspergillus flavus, Rhizoctonia phaseoli, and Penicillium chrysogenum [13] . On the other hand, Aguilar-Guaddarama et al.

shed some positive light on the anti-fungal potential of taraxerol [64] . The authors focused on another type of fungus known as dermatophytes, which are pathogens that cause skin diseases in animals and humans [107] . The compound exhibited strong antidermatophytic activities against various dermatophytes, at varying degrees of inhibition.

Taraxerol was particularly effective against several species of Trichophyton, for instance T. rubrum and T. mentagrophytes, with an MIC of 12.5 µg/mL, as well as Candida albicans (MIC = 25 µg/mL) and Aspergillus niger at 100 µg/mL [64] .

Chaturvedula et al. (2004) found taraxerol at a concentration of 21.8 µg/mL was enough to inhibit 50% (IC 50 ) of the growth of the A2780 ovarian carcinoma cell line, although it performed worse than the positive control doxorubicin (IC 50 1-3 ng/mL) [88] . At concentrations lower than 20 µg/mL, it showed little to no effect on the A2780 cell line [30] . Taraxerol also showed cytotoxicity towards the A431 squamous carcinoma cell line at 2.65 µg/mL, even though it was found to be inactive against HeLa, MCF-7, and MRC-5 cancer cell lines. While taraxerol cytotoxicity exhibited low activity compared to positive control doxorubicin, the activity is comparable to that of cisplatin [42] . Taraxerol also showed little to no inhibitory potential against Hypoxia-Induced Factor-1 (HIF-1) protein to reduce hypoxic tumor growth compared to 17-DMAF [17-(dimethylaminoethylamino)-17demethoxygeldanamycin] [53] . However, taraxerol exhibited strong cytotoxicity towards human AGS gastric epithelial cell line at a concentration of 100 µmol/L by elevating cells arresting from complete mitosis and promoting early cell apoptosis rate from 4.45% to 10.29% [108] . Moreover, the report by Kaennakam et al. (2013) [49] contradicted earlier results from Csupor-Lötfer et al. (2011) [42] whereby the former observed that taraxerol displayed potent cytotoxicity to HeLa cells at a concentration of 14.94 µg/mL and to KB cells at a concentration of 13.58 µg/mL. Based on these results, taraxerol shows potential as a chemotherapeutic agent in cancer therapy.

The utility of taraxerol in the treatment of diabetes was reported by Kwon et al. (2008) , in which the compound was tested against the protein tyrosine phosphatase 1B (PTP1B)-a negative regulator of the insulin-signalling pathway for the treatment of type 2 diabetes [92] . Taraxerol was shown to exhibit moderate inhibitory properties against PTP1B at concentrations higher than 50 µM. Yet, Sangeetha et al. (2010) discovered that instead of targeting the PTP1B protein, taraxerol holds the potential to treat type 2 diabetes by dual action: as a glucose transport activator and as a glycogen synthesis stimulant [109] . The authors also revealed that taraxerol could reverse the effects of dexamethasone-induced insulin resistance back to its normal homoeostasis state. These findings were supported by Gururaja et al. (2015) who claimed that taraxerol is one of the active compounds that shows inhibitory activities against cholesterol esterase enzyme [18] . The antidiabetic properties of taraxerol were mostly attributed to its high affinity towards proteins involved in glucose metabolism [71] .

Perhaps the most potent pharmacological properties actively shown by taraxerol is as an anti-inflammatory agent. Singh et al. (2002) investigated the anti-inflammatory activity of taraxerol on carrageenan-induced paw edema on rats and found that applying the triterpenoid extract at a dosage of 20 mg/kg led to edema reduction by 49.66% after 7 h [13] . Naik et al. (2004) further uncovered the anti-inflammatory effects of taraxerol on TPA-induced local inflammation in Swiss Albino mice, in which development of ear edema in rat model was suppressed following its application. A dosage of 1 mg/ear showed the best suppressive effects with a 25.7 mm difference in ear thickness 4 h following the injection [31] . Apart from paw and ear inflammation, taraxerol was also found to be beneficial in inflammatory pulmonary diseases. By directly acting on airway epithelial cells, taraxerol regulates the expression of the Muc5a gene in the cells, thus regulating mucus production in the inflamed airway [45] .

Other than in the treatment of edema, taraxerol's neuroinflammation amelioration effect has also been studied. Tsao et al. (2008) examined the effect of taraxerol on the production of nitric oxide (NO) and reactive oxygen species (ROS) by activated microglial cells, which play a number of deleterious roles in central nervous system mediation [24] . The NO and ROS are produced by activated microglial cells through the induction of NADPH oxidase (NOX) and nitric oxide synthase (NOS), which the authors noted to have been inhibited by 11.6% at 50 µM concentration and 50% at 24.2 µM concentration, respectively. The mechanism through which taraxerol functions as an anti-inflammatory agent was further elucidated by Yao et al. (2013) who showed that taraxerol downregulates the expression of proinflammatory mediators in macrophages through the interference of TAK1 and Akt protein activation, thus preventing NF-κB activation from producing various proinflammatory mediators through a cascade effect [110] . Cellular redox reactions have a critical role in the regulation of immune response, which directly suggested that taraxerol could also mediate inflammatory responses [110] .

Taraxerol has also been extensively studied for its potential in treating neurodegenerative diseases. Cholinesterase enzymes were targeted by various target compounds in drug development to find possible treatments for neurodegenerative diseases, particularly Alzheimer's [111] . Lee et al. (2004) found the potential of taraxerol for this purpose by inhibiting acetylcholinesterase (AChE) activity in a dose-dependent manner, with an IC 50 value of 33.6 µg/mL [75] . This finding was supported by Jamila et al. (2014) in which taraxerol could not exercise its inhibitory effects at concentrations higher than 33.6 µg/mL [71] . Nevertheless, at 50 µg/mL, taraxerol exhibited inhibitory effects on butyrylcholinesterase (BChE) with 98.4% inhibition [71] . The IC 50 of taraxerol against BChE was found to be at 17.8 µM.

Furthermore, taraxerol displayed high binding affinity to the monomers and mature fibrils of amyloid peptides, which are critical proteins associated with neurodegenerative disorders [111] . Taraxerol can completely assimilate into the human body and cross the blood-brain barrier, which are the two prerequisites for the development of a potent neurodegenerative drug [15] . In silico analysis of taraxerol affinity towards acetylcholinesterase A and B revealed high affinity towards both enzymes through the formation of hydrogen bonds [71] . This might explain the ability of taraxerol to compete for the active site of acetylcholinesterase, thereby exhibiting potential as a treatment for neurodegenerative diseases.

Taraxerol also exhibited wound healing properties. Naik et al. (2004) tested taraxerol for its inhibition on glycogen synthase kinase-3β (GSK-3β) protein, a wound healing biomarker through molecular and dynamic approach [31] . In silico studies have indicated that taraxerol may be a potent inhibitor of GSK-3β due to its expressed minimum binding (−12.59 kJ/mol) and docking energy (−11.25 kJ/mol). On the other hand, in vivo studies have shown that taraxerol displayed an astounding capability in healing three types of wounds, namely excised wounds (18.28 days with 94.42% enclosure), incised wounds (epidermal tensile strength of 562.36 g after 10 days of wounding), and dead space wounds (increased weight of granuloma tissues up to 21.02 mg, tissue breaking strength at 657.12 g, and hydroxyproline content of 1455.93 µg/100 g). Thus, the therapeutic properties of taraxerol can be extended to wound healing and remain to be further explored.

Natural compounds and extracts have been an important source for alternative medicine. The specific chemical compounds that have been isolated from natural plants hold a great potential in medicine, as had been demonstrated by the high number of FDA-approved drugs or natural products as well as their derivatives [112] . The search for antivirals is gaining popularity due to the coronavirus disease 2019 (COVID-19) which have had a huge impact on human well-being. Several phytochemicals such as friedelin, stigmasterol, and taraxerol were reported to exhibit promising antiviral properties [113] . Molecular dynamics simulation demonstrated that taraxerol has a better binding energy with viral proteins such as spike protein, main protease enzyme M pro , and the RNA-dependent RNA polymerase of COVID-19 [113] . This has shed light into further evaluation of taraxerol using in vitro and in vivo experiments for the development of a COVID-19 inhibitor.

Cell culture techniques have emerged as an attractive alternative for the production of plants' secondary metabolites, and various strategies have been developed for use in biomass accumulation as well as synthesis of a slew of secondary compounds [3] . However, taraxerol production through in vitro techniques has been limited so far. An example is the protocol developed by Swain et al. (2012) for producing taraxerol from Clitoria ternatea (Butterfly pea) through the establishment of transformed hairy root cultures [94] . Transformed hairy roots contained integrated T L -rolB gene and were able to increase taraxerol four-fold greater by dry weight basis compared to natural roots. Since transformation was involved in the process, the taraxerol isolated were ascertained by IR, 1 H-NMR, and 1 C-NMR spectroscopy as the modification of the Clitoria ternatea genetic make-up could change its phytochemical content.

Zafar & Sharma (2015) also used an in vitro approach to produce taraxerol through the establishment of callus cultures from the roots of Taraxacum officinale (Dandelion) [114] . Calluses were induced from the roots of Taraxacum officinale by using two types of MS media supplemented with 0.5 mg/L IAA + 1 mg/L BAP + 0.5 mg/L 2,4-D and 2 mg/L IAA + 1 mg/L BAP. The established root callus has successfully increased the taraxerol yield by 1.04 times. To further enhance taraxerol production, Zafar & Sharma (2015) established root callus suspension cultures using the same MS media and PGR combinations from Sharma and Zafar (2014) with the addition of methyl jasmonate (MJ) and β-cyclodextrin (CD) as elicitor agents [16, 114] . According to the authors, both elicitors were able to elevate taraxerol production by 0.018% with MJ at 0.05 mM, 0.1 mM, and 0.2 mM, and by 0.023% with 25 mM β-CD compared to natural roots.

Taraxerol is a bioactive metabolite present in some higher plants which possesses multiple selective biological actions, especially in medicinal applications. Despite displaying little anti oxidative abilities and only moderate antimicrobial properties, various studies have reported the potential of taraxerol to act as an anti-plasmodial, antidiabetic, anticancer, anti-inflammatory, and anti-dermatophyte. These findings demonstrated the potential of taraxerol in the development of a novel and multipurpose drug. From a commercial point of view, taraxerol is hitherto a costly compound to chemically and biologically synthesize. With several pathways towards in vitro synthesis of taraxerol having already been established, it may not be a good use of resources to continue exploring more alternative synthesis pathways. Instead, research efforts should be directed towards optimizing known synthesis techniques through an experimental approach by the establishment of high-yielding cell lines, optimizing culture conditions, nutrient media, phytohormone contents and carbohydrate sources, elicitors, and precursors. With enhanced taraxerol production, further drug research and development works for various treatments using taraxerol can be performed. 

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Drug Discovery from Plants

The Success of Natural Products in Drug Discovery

Production of Secondary Metabolites from Cell and Organ Cultures: Strategies and Approaches for Biomass Improvement and Metabolite Accumulation

Natural Products as Sources of New Drugs over the 30 Years from 1981 to 2010

Natural Products to Drugs: Natural Product-Derived Compounds in Clinical Trials

The Pentacyclic Triterpenoids in Herbal Medicines and Their Pharmacological Activities in Diabetes and Diabetic Complications

Biology and Clinical Significance of Pentacyclic Triterpenes: A Multi-Target Approach to Prevention and Treatment of Metabolic and Vascular Diseases

Triterpenoids and sterols from Hypericum perforatum

Validation of HPTLC Method for the Analysis of Taraxerol in Clitoria ternatea

Reversal of Dexamethasone Induced Insulin Resistance in 3T3L1 Adipocytes by 3β-Taraxerol of Mangifera Indica

Anti-Carcinogenic Activity of Taraxacum Plant. I

Anti-Inflammatory and Antimicrobial Activities of Triterpenoids from Strobilanthes Callosus Nees

A pentacyclic triterpenoid possessing anti-inflammatory activity from the fruits of Dregea volubilis

Top-Leads from Natural Products for Treatment of Alzheimer's Disease: Docking and Molecular Dynamics Study

Optimization of Methyl Jasmonate and β-Cyclodextrin for Enhanced Production of Taraxerol and Taraxasterol in (Taraxacum officinale Weber) Cultures

Part XXXVII. The Constitution of Taraxerol

Cholesterol Esterase Inhibitory Activity of Bioactives from Leaves of Mangifera indica L

Chemical constituents of the leaves of Acanthopanax trifoliatus (Linn) Merr. Zhongguo Zhong Yao Za Zhi

Mangiferonic Acid, 22-Hydroxyhopan-3-One, and Physcion as Specific Chemical Markers for Alnus nepalensis

Determination of the Phenolic Content and Antioxidant Potential of Crude Extracts and Isolated Compounds from Leaves of Cordia multispicata and Tournefortia bicolor

Pereskia aculeata Miller Leaves Present In Vivo Topical Anti-Inflammatory Activity in Models of Acute and Chronic Dermatitis

Antimicrobial Activity and Cytotoxicity of Triterpenes Isolated from Leaves of Maytenus undata (Celastraceae)

New Diterpenoids and the Bioactivity of Erythrophleum fordii

Pentacyclic Triterpenes with Selective Bioactivity from Sebastiania adenophora Leaves

Isolation and characterization of xanthine oxidase inhibitory constituents of Pyrenacantha staudtii

Chemical constituents of Clerodendrum trichotomum Leaves

Malvaceae) Leaf Extract Attenuates Diabetes Induced Nephropathy and Cardiomyopathy via Inhibition of Oxidative Stress and Inflammatory Response

Cloning and Characterization of Farnesyl Diphosphate Synthase Gene Involved in Triterpenoids Biosynthesis from Poria cocos

Antiproliferative Compounds of Helmiopsis sphaerocarpa from the Madagascar Rainforest

Taraxer-14-En-3β-Ol, an Anti-Inflammatory Compound from Sterculia foetida L

Oleanane-Type Triterpenes of Embelia schimperi Leaves

Antifungal activity of Eugenia umbelliflora against dermatophytes

Molecular Docking and Dynamic Studies of Bioactive Compounds from Naravelia zeylanica (L.) DC against Glycogen Synthase Kinase-3β

Chemical constituents in the leave of Rhizophora stylosa L and their biological activities

Rhizophora mangle (Rhizophoraceae) Triterpenoids with Insecticidal Activity

Characterization of Triterpenoid Profiles and Triterpene Synthase Expression in the Leaves of Eight Vitis vinifera Cultivars Grown in the Upper Rhine Valley

Long Chain Cyclohexenones and Cyclohexenols from Lannea schimperi (Anacardiaceae)

Antifungal and Anthelmintic Activities of Root Barks of Uvaria hookeri and Uvaria narum

Antinociceptive and Anti-Inflammatory Activities of Schefflera octophylla Extracts

A new ceramide along with eight known compounds from the roots of Artemisia incisa pamp

Antiproliferative Constituents of the Roots of Conyza canadensis

Chemical constituents from the roots of Homonoia riparia. Yao Xue Xue Bao

A New Cytotoxic Prenylated Dihydrobenzofuran Derivative and Other Chemical Constituents from the Rhizomes of Atractylodes lancea DC

Effects of Lupenone, Lupeol, and Taraxerol Derived From Adenophora triphyllaon the Gene Expression and Production of Airway MUC5AC Mucin

Studies on chemical constituents of root tuber of cultivated Pseudostellaria heterophylla

Studies on the chemical constituents of the roots of Rhododendron molle G. Don

Study on chemical constituents of root bark of Discocleidion rufescens

Tip-pyang, S. A New Taraxerol Derivative from the Roots of Microcos tomentosa

Triterpenoids from the Roots of Pterospermum heterophyllum Hance

Thonningiiflavanonol A and Thonningiiflavanonol B, Two Novel Flavonoids, and Other Constituents of Ficus thonningii Blume (Moraceae)

Isolation of Myricadiol, Myricitrin, Taraxerol, and Taraxerone from Myrica cerifera L. Root Bark

Triterpenoids and Diarylheptanoids from Alnus hirsuta Inhibit HIF-1 in Ags Cells

Two Novel C29-5β-Sterols from the Stems of Opuntia dillenii

A New Triterpenoid from Sapium baccatum (Euphorbiaceae). Former

Triterpenes from Euphorbia hirta and Their Cytotoxicity. Chin

Isolation of Terpenoids from the Stem of Ficus aurantiaca Griff and Their Effects on Reactive Oxygen Species Production and Chemotactic Activity of Neutrophils

New Sesquiterpenes and Phenolic Compound from Ficus foveolata

Cytotoxic Principles from Ventilago leiocarpa

Chemical constituents in the leaves of Mangifera persiciformis

Study on the chemical constituents of Uvaria microcarpa

Studies on chemical constituents of Uvaria macrophylia

A New Pregnane Glycoside from Gomphocarpus fruticosus Growing in Egypt

Active Compounds against Tinea Pedis Dermatophytes from Ageratina pichinchensis var. bustamenta

Identification and Determination of Triterpenoids in Hieracium pilosella L

Triterpene Alcohols from the Flowers of Compositae and Their Anti-Inflammatory Effects

Unsaponifiable Lipid Constituents of Ten Indian Seed Oils

Distribution of Pyranocoumarins in Calophyllum Cordato-Oblongum

Studies on the chemical constituents of Codonopsis pilosula

Chemical components of Codonopsis pilosula (Franch.) Nannf. var. volubilis (Nannf

Cholinesterase Inhibitory Triterpenoids from the Bark of Garcinia hombroniana

Cloning and Characterization of Oxidosqualene Cyclases from Kalanchoe daigremontiana

Studies on the chemical constituents of Vaccinium iteophyllum

The chemical constituents of Rhododendron ovatum Planch

Acetylcholinesterase Inhibitors from the Twigs of Vaccinium Oldhami Miquel

Anti-Inflammatory Diterpene from Thyrsanthera suborbicularis

Terpenoids from Euphorbia antiquorum L. Yao Xue Xue Bao

Studies on the chemical constituents from Euphorbia chrysocoma

Potential Cancer Chemopreventive Constituents of the Leaves of Macaranga triloba

A Phytochemical Investigation of Alchornea latifolia

Studies on the triterpenoids of Vitex trifolia

Studies on chemical constituents of Clerodendrum bungei

Two new 18-en-oleane derivatives from marine mangrove plant, Barringtonia racemosa

Anin Vitro Inhibitor of Photosynthesis Isolated from Pavonia multiflora A. St-Hil. (Malvaceae)

A New Cinnamoylglycoflavonoid, Antimycobacterial and Antioxidant Constituents from Heritiera littoralis leaf Extracts

A new triterpenoid: Taraxerol-3-beta-O-tridecyl ether from Derris triofoliata

Study on the chemical constituents of Mitragyna rotundifolia

New Cytotoxic Terpenoids from the Wood of Vepris punctata from the Madagascar Rainforest

Antiparasitic Compounds from Cupania cinerea with Activities against Plasmodium falciparum and Trypanosoma bruceirhodesiense

The Chemical Composition of Cuticular Waxes from Leaves of the Gboma Eggplant (Solanum macrocarpon L.)

Triterpenoids and a Sterol from the Stem-Bark of Styrax japonicaand Their Protein Tyrosine Phosphatase 1B Inhibitory Activities

A study on chemical components of Tetrastigma hemsleyanum Diels et Gilg. Native to China

Production of Triterpenoid Anti-Cancer Compound Taraxerol in Agrobacterium-Transformed Root Cultures of Butterfly Pea

Remarkable Diversity of Form and Function

Enzymes of the Mevalonate Pathway of Isoprenoid Biosynthesis

Cloning of an Arabidopsis thaliana CDNA Coding for Farnesyl Diphosphate Synthase by Functional Complementation in Yeast

Mechanism of the Biosynthesis of Squalene from Farnesyl Pyrophosphate

Structure and Regulation of Mammalian Squalene Synthase

Enzymatic Synthesis of Cyclic Triterpenes

Enzymatic Cyclization of Squalene and Oxidosqualene to Sterols and Triterpenes

Triterpene Synthases from the Okinawan Mangrove Tribe, Rhizophoraceae

New Furofuran and Butyrolactone Lignans with Antioxidant Activity from the Stem Bark of Styrax japonica

Antigiardial Activity of Cupania dentata Bark and Its Constituents

Anti-Plasmodial Activity of Some Zulu Medicinal Plants and of Some Triterpenes Isolated from Them

Interactions of Antiparasitic Sterols with Sterol 14α-Demethylase (CYP51) of Human Pathogens

Essential Oils for Treatment for Onychomycosis: A Mini-Review

Effects of Taraxerol and Taraxeryl Acetate on Cell Cycle and Apoptosis of Human Gastric Epithelial Cell Line AGS

S. 3β-Taraxerol of Mangifera Indica, a PI3K Dependent Dual Activator of Glucose Transport and Glycogen Synthesis in 3T3-L1 Adipocytes

Taraxerol Inhibits LPS-Induced Inflammatory Responses through Suppression of TAK1 and Akt Activation

Therapeutic Strategies for Alzheimer's Disease in Clinical Trials

An analysis of FDA-approved drugs: Natural products and their derivatives

Natural Compounds from Clerodendrum Spp. as Possible Therapeutic Candidates against SARS-CoV-2: An In Silico Investigation

Occurrence of Taraxerol and Taraxasterol in Medicinal Plants